Other
Journal
About P&T Journal
Contacts:Editor:
ssherritze@medimedia.com
Advertising:
mliberti@medimedia.com
Circulation:
lgardineer@medimedia.com
Production:
wpeart@medimedia.com
Rate Card
Production Specifications
Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints
Recent Issues
May 2007
Features
Commentary
Consumer-Directed Health Plans: Where Are We Now?
Although several years have passed since health savings accounts became available to Americans, the number of enrollees has remained relatively low. This article explores some of the pitfalls of the plans and the reluctance of the public to climb aboard.
Miriam Reisman
P&T Around the world
Lessons Learned from a Global Sentinel Event: Priorix Vaccine Returns to Vietnam
The authors present an update to an earlier P&T article on the embargo of Priorix measles–mumps–rubella vaccine after a deadly health scare in Ho Chi Minh City.
Peter Teichman, MD, and Nguyen Tri Doan, MD
Considerations Associated with Therapeutic Interchange within the Fluoroquinolone Class of Antimicrobials
The author discusses the procedures, safeguards, and costs involved when less expensive agents replace preferred drugs in the same pharmacological class.
Robert P. Rapp, PharmD, FCCP
NSAID Usage: Impact of Safety Data and Product Withdrawals on Prescribing Trends
The authors describe the changes in the prescribing patterns for NSAIDs that resulted when valdecoxib (Bextra) and rofecoxib (Vioxx) were withdrawn from the market.
Molly T. Vogt, PhD, Bethany Fedutes-Henderson, PharmD, Amit Duggal, PharmD, MPH, Nicole T. Ansani, PharmD, John Gillespie, MD, and Terence Starz, MD
Book Review
Miracle Medicines: Seven Lifesaving Drugs and the People Who Created Them
Author: Robert L. Shook
Reviewed by Burton Orland, BS, RPh
Pharmaceutical Approval Update
Sitagliptin/metformin (Janumet) for diabetes, lapatinib (Tykerb) for HER-2–positive breast cancer, and protein C concentrate powder (Ceprotin) for venous disorders are reviewed.
Marvin M. Goldenberg, PhD, RPh, MS
Departments
Editorial
Consumer Engagement
David Nash, MD, MBA, reports on the results of a BlueCross BlueShield survey on how consumers use the Internet to obtain information about medical treatments.
David B. Nash, MD, MBA
Medication Errors
Nix the Quick Fix: Adopting New Drug Protocols Requires Groundwork
Matthew Grissinger, RPh, FASCP, explains the potential problems that can result when new medication protocols are implemented too quickly.
Matthew Grissinger, RPh, FASCP
Prescription: Washington
Congress Tries to Strengthen Drug-Testing Laws for Children
Stephen Barlas discusses forthcoming changes to two laws calling for pediatric drug-testing trials.
Stephen Barlas
New Drugs/Drug News
P&T presents the latest studies and information about FDA approvals, drug indications, industry updates, and new devices.
Drug Forecast
Dabigatran (Rendix): A Promising New Oral Direct Thrombin Inhibitor
Dr. Paris Abrams and Dr. Nino Marzella review dabigatran (Rendix), a direct thrombin inhibitor.
Paris Abrams, PharmD, and Nino Marzella, BS, PharmD
